The Joint (JYNT)
Search documents
The Joint (JYNT) - 2023 Q3 - Quarterly Report
2023-11-12 16:00
(480) 245-5960 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to _________________ Commission file number: 001-36724 The Joint Corp. (Exact name of registrant as specified in its cha ...
The Joint (JYNT) - 2023 Q2 - Quarterly Report
2023-09-25 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to _________________ Commission file number: 001-36724 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware (State or other ju ...
The Joint (JYNT) - 2023 Q2 - Earnings Call Transcript
2023-09-15 16:34
The Joint Corp. (NASDAQ:JYNT) Q2 2023 Earnings Conference Call September 13, 2023 5:00 PM ET Company Participants Kirsten Chapman - Managing Director and Principal, HA Investor Relations Peter Holt - President and Chief Executive Officer Jake Singleton - Chief Financial Officer Conference Call Participants Richard Magnusen - B. Riley FBR George Kelly - ROTH MKM Anthony Vendetti - Maxim Group Operator Good afternoon, and welcome to the preliminary Q2 2023 Financial Review for The Joint Conference Call. All p ...
The Joint (JYNT) - 2023 Q1 - Quarterly Report
2023-05-04 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to _________________ Commission file number: 001-36724 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware (State or other j ...
The Joint (JYNT) - 2022 Q4 - Earnings Call Transcript
2023-03-10 01:19
The Joint Corp. (NASDAQ:JYNT) Q4 2022 Earnings Conference Call March 9, 2023 5:00 PM ET Company Participants David Barnard - LHA Investor Relations Peter Holt - President and CEO Jake Singleton - CFO Conference Call Participants Jeff Van Sinderen - B. Riley FBR Anthony Vendetti - Maxim Group George Kelly - ROTH Capital Partners Brooks O'Neil - Lake Street Capital Markets Linda Bolton Weiser - DA Davidson Operator Good day, and welcome to The Joint Fourth Quarter 2022 Financial Results Conference Call. [Oper ...
The Joint (JYNT) - 2022 Q4 - Earnings Call Presentation
2023-03-09 22:14
3 Strong Operational KPIs The Joint is revolutionizing care by making it affordable, convenient and accessible. Leadership Culture Chiropractic © 2023 The Joint Corp. All Rights Reserved. 2 Our mission is to improve quality of life through routine and affordable chiropractic care. Q4 2022 Financial Results As of December 31, 2022 | Reported on March 9, 2023 © 2023 The Joint Corp. All Rights Reserved. 110 121 Safe Harbor Statements Certain statements contained in this presentation are "forward-looking statem ...
The Joint (JYNT) - 2022 Q4 - Annual Report
2023-03-09 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to ________ Commission File Number: 001-36724 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 90-0544160 (State or Other Jurisdiction ...
The Joint (JYNT) - 2022 Q3 - Earnings Call Transcript
2022-11-06 15:55
The Joint Corp. (OTCQB:JSDA) Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants David Barnard - LHA Investor Relations Peter Holt - President and CEO Jake Singleton - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets George Kelly - ROTH Capital Partners Jeremy Hamblin - Craig-Hallum Capital Group Jeffrey Van Sinderen - B. Riley FBR Operator Good day, and welcome to The Joint Corp. Third Quarter 2022 Financial Results Conference Call. [Operator Instru ...
The Joint (JYNT) - 2022 Q3 - Quarterly Report
2022-11-04 13:33
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to _________________ Commission file number: 001-36724 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware (State or oth ...
The Joint (JYNT) - 2022 Q2 - Earnings Call Transcript
2022-08-07 07:26
The Joint Corp. (NASDAQ:JYNT) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants David Barnard – LHA Investor Relations Peter Holt – President and Chief Executive Officer Jake Singleton – Chief Financial Officer Conference Call Participants Jeremy Hamblin – Craig Capital Jeff Van Sinderen – B. Riley Brooks O’Neil – Lake Street Capital George Kelly – ROTH Capital Partners Anthony Vendetti – Maxim Group Operator Welcome to The Joint Corp.’s Second Quarter 2022 Financial Results Co ...